Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FRANK MCGREW

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1922190396
CMS profile
314413
Location
MEMPHIS, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$13,423.03

162 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FRANK MCGREW

NPI 1922190396 · CMS profile ID 314413

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

MEMPHIS, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1922190396?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FRANK MCGREW, NPI 1922190396, CMS profile ID 314413. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1922190396?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). FRANK MCGREW, NPI 1922190396, CMS profile ID 314413. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1922190396?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
FRANK MCGREW, NPI 1922190396, CMS profile ID 314413, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 162 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1922190396?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

162 matching records · $13,423.03 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 162 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 162.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Actelion Pharmaceuticals US, Inc. $23.5608/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174294234 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.3308/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647602 CMS
Xeris Pharmaceuticals, Inc. $23.9408/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250157394 CMS
VivaQuant Inc, dba Rhythm Express $29.7508/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250414929 CMS
Novartis Pharmaceuticals Corporation $19.4708/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200723833 CMS
Alnylam Pharmaceuticals Inc. $29.6408/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212742075 CMS
Alnylam Pharmaceuticals Inc. $6.9708/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212742077 CMS
BridgeBio Pharma, Inc. $20.6608/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250455990 CMS
Alnylam Pharmaceuticals Inc. $25.5808/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212742073 CMS
Novo Nordisk Inc $20.9908/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188211183 CMS
Astellas Pharma US Inc $24.8607/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238772606 CMS
Merck Sharp & Dohme LLC $17.1207/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238302107 CMS
Bayer Healthcare Pharmaceuticals Inc. $26.0707/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647600 CMS
Daiichi Sankyo Inc. $23.7507/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197088757 CMS
E.R. Squibb & Sons, L.L.C. $22.2807/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184794750 CMS
Novartis Pharmaceuticals Corporation $16.4907/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200723831 CMS
Actelion Pharmaceuticals US, Inc. $23.5607/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174293558 CMS
AstraZeneca Pharmaceuticals LP $23.1307/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206622612 CMS
Bayer Healthcare Pharmaceuticals Inc. $26.0406/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647598 CMS
Novartis Pharmaceuticals Corporation $16.7306/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200723835 CMS
Alnylam Pharmaceuticals Inc. $21.7506/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212742061 CMS
Merck Sharp & Dohme LLC $20.1306/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238347282 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.1106/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647584 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.5906/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222894821 CMS
Bayer Healthcare Pharmaceuticals Inc. $6.6406/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647590 CMS
E.R. Squibb & Sons, L.L.C. $22.8306/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184794736 CMS
Novartis Pharmaceuticals Corporation $15.4806/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200723829 CMS
Daiichi Sankyo Inc. $20.0806/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197078267 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.7106/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647582 CMS
E.R. Squibb & Sons, L.L.C. $4,620.0006/04/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1184794720 CMS
Actelion Pharmaceuticals US, Inc. $17.2706/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174293303 CMS
Boston Scientific Corporation $23.5805/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181354874 CMS
Amgen Inc. $16.1205/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228636311 CMS
Amgen Inc. $21.4905/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228636319 CMS
BridgeBio Pharma, Inc. $23.0905/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250455975 CMS
Novartis Pharmaceuticals Corporation $20.3605/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200723819 CMS
Novo Nordisk Inc $26.2505/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188250489 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.6505/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647596 CMS
Merck Sharp & Dohme LLC $16.4005/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238214080 CMS
Actelion Pharmaceuticals US, Inc. $15.2405/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174293406 CMS
Novartis Pharmaceuticals Corporation $24.5305/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200723823 CMS
E.R. Squibb & Sons, L.L.C. $24.7905/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184794726 CMS
Inspire Medical Systems, Inc. $23.7205/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251488621 CMS
AstraZeneca Pharmaceuticals LP $25.3305/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206276266 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.5605/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222894819 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.8404/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225647588 CMS
Impulse Dynamics (USA) Inc. $143.3404/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223113884 CMS
Medtronic, Inc. $103.2804/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219111810 CMS
Alnylam Pharmaceuticals Inc. $23.7604/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212742013 CMS
Merck Sharp & Dohme LLC $21.7704/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238347398 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $38,310.26 271
PY2020 $8,172.44 73
PY2021 $8,531.98 140
PY2022 $19,406.69 213
PY2023 $17,431.29 204
PY2024 $13,899.93 174
PY2025 $13,423.03 162

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $226,782.19 49
PY2024 Principal investigator $264,716.33 70
PY2023 Principal investigator $285,486.35 59
PY2022 Principal investigator $182,112.19 93
PY2021 Principal investigator $232,448.15 130
PY2020 Principal investigator $312,107.86 119
PY2019 Principal investigator $505,872.05 145

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

49 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $518.40 12/05/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM No dispute reported 06/30/2026 1248068649
Principal investigator 1 Impulse Dynamics (USA) Inc. $270.00 12/01/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214122602
Principal investigator 1 Impulse Dynamics (USA) Inc. $840.00 12/01/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214122614
Principal investigator 1 Novartis Pharmaceuticals Corporation $53.46 11/15/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR CENTER
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190302905
Principal investigator 1 Impulse Dynamics (USA) Inc. $120.00 11/03/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214122604
Principal investigator 1 Impulse Dynamics (USA) Inc. $270.00 11/03/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214122616
Principal investigator 1 Amgen Inc. $4,875.46 10/28/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246648754
Principal investigator 1 CVRx, Inc. $12,804.00 10/28/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698658
Principal investigator 1 Medtronic, Inc. $1,191.00 09/11/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319248
Principal investigator 1 Medtronic, Inc. $200.00 09/10/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319250
Principal investigator 1 Medtronic, Inc. $1,250.00 09/04/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319246
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $2,047.00 09/03/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM / Sotagliflozin / LX4211 No dispute reported 06/30/2026 1248067361
Principal investigator 1 Novartis Pharmaceuticals Corporation $14,254.96 08/19/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR CENTER
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190302907
Principal investigator 1 Alnylam Pharmaceuticals Inc. $1,125.00 08/01/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) No dispute reported 06/30/2026 1215516169
Principal investigator 1 Alnylam Pharmaceuticals Inc. $700.00 08/01/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) No dispute reported 06/30/2026 1215516172
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,300.00 08/01/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) No dispute reported 06/30/2026 1215516176
Principal investigator 1 Impulse Dynamics (USA) Inc. $3,120.00 08/01/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214122596
Principal investigator 1 Medtronic, Inc. $343.00 08/01/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319244
Principal investigator 1 Medtronic, Inc. $1,026.00 07/30/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319242
Principal investigator 1 CVRx, Inc. $3,510.00 07/28/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698654
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $192.00 07/09/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM / Sotagliflozin / LX4211 No dispute reported 06/30/2026 1248066951
Principal investigator 1 Medtronic, Inc. $4,444.00 07/09/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319240
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $3,879.00 06/23/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM No dispute reported 06/30/2026 1248066665
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $750.00 06/23/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM No dispute reported 06/30/2026 1248066667
Principal investigator 1 CVRx, Inc. $51,510.00 05/06/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698660
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $2,683.80 04/30/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM / Sotagliflozin / LX4211 No dispute reported 06/30/2026 1248068181
Principal investigator 1 CVRx, Inc. $624.00 04/25/2025 Non-covered Recipient Entity
WCG IRB
Not supplied No dispute reported 06/30/2026 1228698770
Principal investigator 1 Amgen Inc. $6,995.00 04/23/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
The African American Heart Study: A Real-World Data Study of Atherosclerotic Cardiovascular Risk in African American and Black Participants in the US No dispute reported 06/30/2026 1246648762
Principal investigator 1 AstraZeneca UK Limited $20,425.00 04/14/2025 Non-covered Recipient Entity
DUKE UNIVERSITY
A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function No dispute reported 06/30/2026 1185548155
Principal investigator 1 CVRx, Inc. $150.00 04/08/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698650
Principal investigator 1 CVRx, Inc. $2,153.30 04/03/2025 Non-covered Recipient Entity
WCG IRB
Not supplied No dispute reported 06/30/2026 1228698836
Principal investigator 1 Impulse Dynamics (USA) Inc. $360.00 03/26/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214122598
Principal investigator 1 Medtronic, Inc. $5,500.00 03/12/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319238
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $15,000.00 03/07/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM / Sotagliflozin / LX4211 No dispute reported 06/30/2026 1248066783
Principal investigator 1 CVRx, Inc. $100.00 03/04/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698648
Principal investigator 1 Alnylam Pharmaceuticals Inc. $500.00 03/03/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) No dispute reported 06/30/2026 1215516159
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,432.30 02/21/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) No dispute reported 06/30/2026 1215516163
Principal investigator 1 Medtronic, Inc. $120.00 02/10/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319236
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,637.73 02/10/2025 Non-covered Recipient Entity
ADVANCED MED IMAGING NUCL
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardi No dispute reported 06/30/2026 1190308052
Principal investigator 1 CVRx, Inc. $7,272.00 02/05/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698656
Principal investigator 1 Novartis Pharmaceuticals Corporation $12,682.12 01/28/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR FOUNDATION
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190307409
Principal investigator 1 CVRx, Inc. $550.00 01/27/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698652
Principal investigator 1 Medtronic, Inc. $263.00 01/24/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
ALLEVIATE-HF No dispute reported 06/30/2026 1192319234
Principal investigator 1 Amgen Inc. $23,666.53 01/15/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a) No dispute reported 06/30/2026 1246648750
Principal investigator 1 Impulse Dynamics (USA) Inc. $1,040.00 01/15/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214122600
Principal investigator 1 Novartis Pharmaceuticals Corporation $533.03 01/15/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR CENTER
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190302909
Principal investigator 1 Lexicon Pharmaceuticals, Inc. $6,956.10 01/14/2025 Non-covered Recipient Entity
The Stern Cardiovascular Foundation
SONATA-HCM / Sotagliflozin / LX4211 No dispute reported 06/30/2026 1248066249
Principal investigator 1 CVRx, Inc. $100.00 01/07/2025 Non-covered Recipient Entity
Stern Cardiovascular Foundation Inc
Not supplied No dispute reported 06/30/2026 1228698646
Principal investigator 1 Novartis Pharmaceuticals Corporation $3,445.00 01/07/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR FOUNDATION
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardi No dispute reported 06/30/2026 1190307413